Dillico is a deep technology business that is developing new equipment to simplify and improve the production of mRNA vaccines & medicines.
Dillico has raised $8.8M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Dillico's investors include Deeperly, France 2030, Auvergne-Rhône-Alpes Regional Future Industry Fund, Angelor, Deepbright Ventures.
Dillico is headquartered in Meylan, France.
Dillico is a deep technology business that is developing new equipment to simplify and improve the production of mRNA vaccines & medicines.
Dillico is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dillico — Funding & Investors." VCBacked, July 9, 2025, https://www.vcbacked.co/company/dillico. Accessed August 2, 2026.
VCBacked. (2025). Dillico — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/dillico
{{cite web |title=Dillico — Funding & Investors |url=https://www.vcbacked.co/company/dillico |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated